{"id":14653,"date":"2012-03-02T08:30:00","date_gmt":"2012-03-02T07:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/sciolta-sanofi-aventis-yamanouchi\/"},"modified":"2012-03-02T08:30:00","modified_gmt":"2012-03-02T07:30:00","slug":"sciolta-sanofi-aventis-yamanouchi","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/sciolta-sanofi-aventis-yamanouchi\/","title":{"rendered":"Sanofi-aventis Yamanouchi dissolved"},"content":{"rendered":"<p style=\"line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\" class=\"MsoNormal\"><span style=\"font-family: BookAntiqua; color: #212120; font-size: 12pt; mso-bidi-font-family: BookAntiqua\"><font face=\"Calibri\"><\/font><\/span><\/p>\n<p style=\"line-height: normal; margin: 0cm 0cm 0pt; mso-layout-grid-align: none\" class=\"MsoNormal\" align=\"right\"><span style=\"font-family: BookAntiqua; color: #212120; font-size: 12pt; mso-bidi-font-family: BookAntiqua\"><font face=\"Calibri\"><img loading=\"lazy\" decoding=\"async\" style=\"padding-bottom: 8px; padding-right: 8px; padding-top: 8px\" id=\"il_fi\" alt=\"\" width=\"135\" height=\"45\" src=\"http:\/\/www.eyeforpharma.com\/salesusa05\/images\/logos\/casestudies\/yamanouchi.gif\" \/><\/font><\/span><\/p>\n<p style=\"line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\" class=\"MsoNormal\"><span style=\"font-family: BookAntiqua; color: #212120; font-size: 12pt; mso-bidi-font-family: BookAntiqua\"><font face=\"Calibri\">Sanofi and Astellas Pharma have agreed to dissolve Sanofi-aventis Yamanouchi Pharmaceutical Inc., a joint company of the two companies. Sanofi-aventis Yamanouchi Pharmaceutical Inc. was founded in 1986 and its shares are currently owned by a subsidiary of Sanofi (for the 51%) and Astellas (for the 49%). The joint venture had the exclusive rights to manufacture and distribute the cardiovascular agent Milrila (milrinone) created by Sanofi in Japan.<\/p>\n<p><\/font><\/span><\/p>\n<p style=\"line-height: normal; margin: 0cm 0cm 0pt; text-autospace: ; mso-layout-grid-align: none\" class=\"MsoNormal\"><span style=\"font-family: BookAntiqua; color: #212120; font-size: 12pt; mso-bidi-font-family: BookAntiqua\"><font face=\"Calibri\">Astellas had been given the rights to manufacture and distribute the drug. However, effective January 1, 2012, Sanofi Aventis USA directly granted Astellas the rights to exclusively manufacture and distribute Milrila in Japan, without involving the joint company. As a result of this change, the joint venture no longer has products to manage and for this reason Sanofi and Astellas have decided to dissolve it.<\/p>\n<p><\/font><\/span><\/p>\n<p style=\"margin: 0cm 0cm 10pt\" class=\"MsoNormal\"><em><span style=\"line-height: 115%; font-family: &quot;Times New Roman&quot;,&quot;serif&quot;; color: #212120; font-size: 9pt; mso-bidi-font-weight: bold\">March 2, 2012 \u2013 PharmaKronos<\/span><\/em><\/p>\n<p style=\"margin: 0cm 0cm 10pt\" class=\"MsoNormal\"><span style=\"line-height: 115%; font-family: BookAntiqua; color: #212120; font-size: 9pt; mso-bidi-font-family: BookAntiqua\"><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" style=\"padding-bottom: 8px; width: 356px; padding-right: 8px; height: 245px; padding-top: 8px\" id=\"il_fi\" alt=\"\" width=\"406\" height=\"295\" src=\"http:\/\/www.yaofang.us\/upload\/product\/2955.jpg\" \/><\/p>\n<p><\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Sanofi e Astellas Pharma hanno deciso di sciogliere Sanofi-aventis Yamanouchi Pharmaceutical Inc., societ&agrave; congiunta delle due aziende. Sanofi-aventis Yamanouchi Pharmaceutical Inc. &egrave; stata fondata nel 1986 e le sue azioni sono attualmente di propriet&agrave; di una filiale di Sanofi (per il 51%) e Astellas (per il 49%). La societ&agrave; comune aveva i diritti esclusivi per &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-14653","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14653","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=14653"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14653\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=14653"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=14653"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=14653"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}